Examples of using Methotrexate in English and their translations into Russian
{-}
-
Official
-
Colloquial
Methotrexate(anti-cancer medicine
It is emphasized that the use of methotrexate allows completely discontinuing hormone therapy in hormone-related forms of UC.
lithium, methotrexate, probenecid, warfarin
Methotrexate is used to treat certain types of cancer of the breast,
Combined use of methotrexate and cyclosporine has been used successfully in the treatment of rheumatoid and psoriatic arthritis.
Xeljanz can be used as monotherapy or in combination with methotrexate or other non-biological disease-modifying antirheumatic drugs(the DMARD) in combination.
N-acetylcysteine, methotrexate, etc..
Aim: the study of the efficacy of methotrexate in patients with the"escape effect" during the ustekinumab therapy.
30- with NSAIDs and methotrexate.
Post-transplant immusupression included Prograf 0.02 mk/kg started at day -1, Methotrexate 5mg/m 2 at days +1, +3, +6.
The results of methotrexate at a dose of 15-20mg/week in treatment of 4 patients receiving biologic
After stable remission was induced, the standard of care previously was to undergo 2 years of maintenance chemotherapy with methotrexate, mercaptopurine and ATRA.
In the course of the long-term treatment of patients with psoriatic arthritis using disease-modifying drugs, a statistically significant decrease in the severity of anxiety-depressive disorders was observed in methotrexate and combination therapy groups.
the selection of genetically engineered biological agents for the treatment of RA after the completion of therapy with tofacitinib administered due to the ineffectiveness of methotrexate is discussed.
consisting of non-specific immunosuppressive agents like calcineurin inhibitors, methotrexate, mycophenolate mofetil,
As a part of basic anti-inflammatory therapy of psoriatic arthritis, methotrexate was used in 67% patients, sulfasalazine in 25% patients, and cyclosporine and D-penicillamine in 4% patients.
The study shows that in the case of the resistance progressing when applying preparations of biological therapy, methotrexate is useful at a dose of 15-20mg/week for up to 6 months.
There are reports of positive results of treatment of melanoma by administering a patient's own lymphocytes treated with activators such as PHA, methotrexate, and others.
agomelatine, methotrexate, theophylline and other derivatives of xanthin,
The combined use of biologic therapy and methotrexate in the treatment of patients with psoriasis vulgaris,"escape effect" contributes to the marked regression of clinical symptoms and allows to control the process long enough,